Drinking 3 to 4 cups of coffee per day may decrease endometrial cancer risk by nearly 20%
the ONA take:
According to a new study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers from Imperial College London in London, United Kingdom, have found that drinking three to four cups of coffee per day may reduce a woman's risk of developing endometrial cancer by nearly a fifth.
For the study, researchers sought to investigate how dietary factors influence the risk of developing endometrial cancer. They analyzed data from 1,303 women with endometrial cancer who participated in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
In that study, participants completed questionnaires about their dietary habits. Results showed that butter, carbohydrates, cheese, coffee, monounsaturated fats, phosphorous, potatoes, and total fat may be associated with risk of endometrial cancer.
Then, researchers analyzed data from 1,531 women with endometrial cancer who participated in the Nurses' Health Study (NHS) or Nurses' Health Study II (NHSII), in which participants also completed dietary questionnaires. The team next looked at the association between the nine foods identified in the EPIC study and risk of endometrial cancer in the NHS and NHSII studies.
They found that drinking three cups of coffee per day decreased endometrial cancer risk by 19% among those in the EPIC study compared with those who drank less than one cup per day.
In addition, the team found that women who drank four cups per day reduced endometrial cancer risk by 18% versus those who never drank coffee in the NHS and NHSII studies.
Drinking three to four cups of coffee per day may reduce a woman's risk of developing endometrial cancer by nearly a fifth.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|